Citius Pharmaceuticals Inc (CTXR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
15,884,100
EV to revenue ratio (TTM)
0.822
EV to ebitda
-2.743
Financial Performance
Revenue (TTM)
7,105,200
Gross profit (TTM)
5,495,300
EBITDA
-53,851,096
Profitability
Operating margin (TTM)
-670.00%
Profit margin
0.00%
Return on assets (TTM)
-26.60%
Return on equity (TTM)
-81.10%
Per Share Metrics
Revenue per share (TTM)
0.33
EPS
-1.75
Diluted EPS (TTM)
-1.75
Book value
2.43
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
0.318
PEG ratio
0
Price to sales ratio (TTM)
2.236
Price to book ratio (TTM)
0.235
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.999